Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data

被引:78
|
作者
Speich, Benjamin [1 ,2 ]
von Niederhaeusern, Belinda [2 ,3 ]
Schur, Nadine [4 ]
Hemkens, Lars G. [1 ,2 ]
Fuerst, Thomas [5 ,6 ]
Bhatnagar, Neera [7 ]
Alturki, Reem [8 ]
Agarwal, Arnav [7 ,9 ]
Kasenda, Benjamin [1 ,2 ,10 ]
Pauli-Magnus, Christiane [2 ,3 ]
Schwenkglenks, Matthias [4 ,11 ]
Briel, Matthias [1 ,2 ,7 ]
机构
[1] Univ Basel, Basel Inst Clin Epidemiol & Biostat, Dept Clin Res, Spitalstr 12, CH-4031 Basel, Switzerland
[2] Univ Hosp Basel, Spitalstr 12, CH-4031 Basel, Switzerland
[3] Univ Basel, Dept Clin Res, Clin Trial Unit, Basel, Switzerland
[4] Univ Basel, Inst Pharmaceut Med, Basel, Switzerland
[5] Univ Basel, Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland
[6] Imperial Coll London, Sch Publ Hlth, London, England
[7] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[8] King Fahad Specialist Hosp Dammam, Multi Organ Transplant Ctr, POB 15215, Dammam 31444, Saudi Arabia
[9] Univ Toronto, Sch Med, Toronto, ON, Canada
[10] Univ Basel, Dept Med Oncol, Basel, Switzerland
[11] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland
关键词
Randomized clinical trials; Clinical trial cost; Cost drivers; Resource use; Systematic review; Trial feasibility; RECRUITMENT METHODS; REDUCING WASTE; PREVENTION TRIAL; DRUG DEVELOPMENT; INCREASING VALUE; PRIMARY-CARE; PATIENT RECRUITMENT; BIOMEDICAL-RESEARCH; ECONOMIC RETURN; HEALTH RESEARCH;
D O I
10.1016/j.jclinepi.2017.12.018
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: Randomized clinical trials (RCTs) are costly. We aimed to provide a systematic overview of the available evidence on resource use and costs for RCTs to support budget planning. Study Design and Setting: We systematically searched MEDLINE, EMBASE, and HealthSTAR from inception until November 30, 2016 without language restrictions. We included any publication reporting empirical data on resource use and costs of RCTs and categorized them depending on whether they reported (i) resource and costs of all aspects at all study stages of an RCT (including conception, planning, preparation, conduct, and all tasks after the last patient has completed the RCT); (ii) on several aspects, (iii) on a single aspect (e.g., recruitment); or (iv) on overall costs for RCTs. Median costs of different recruitment strategies were calculated. Other results (e.g., overall costs) were listed descriptively. All cost data were converted into USD 2017. Results: A total of 56 articles that reported on cost or resource use of RCTs were included. None of the articles provided empirical resource use and cost data for all aspects of an entire RCT. Eight articles presented resource use and cost data on several aspects (e.g., aggregated cost data of different drug development phases, site-specific costs, selected cost components). Thirty-five articles assessed costs of one specific aspect of an RCT (i.e., 30 on recruitment; five others). The median costs per recruited patient were USD 409 (range: USD 41-6,990). Overall costs of an RCT, as provided in 16 articles, ranged from USD 43-103,254 per patient, and USD 0.2-611.5 Mio per RCT but the methodology of gathering these overall estimates remained unclear in 12 out of 16 articles (75%). Conclusion: The usefulness of the available empirical evidence on resource use and costs of RCTs is limited. Transparent and comprehensive resource use and cost data are urgently needed to support budget planning for RCTs and help improve sustainability. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [41] Yoga for low back pain: a systematic review of randomized clinical trials
    Paul Posadzki
    Edzard Ernst
    Clinical Rheumatology, 2011, 30
  • [42] External qigong for pain conditions: A systematic review of randomized clinical trials
    Lee, Myeong Soo
    Pittler, Max H.
    Ernst, Edzard
    JOURNAL OF PAIN, 2007, 8 (11): : 827 - 831
  • [43] Randomized Controlled Trials of Artificial Intelligence in Clinical Practice: Systematic Review
    Lam, Thomas Y. T.
    Cheung, Max F. K.
    Munro, Yasmin L.
    Lim, Kong Meng
    Shung, Dennis
    Sung, Joseph J. Y.
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2022, 24 (08)
  • [44] Diversity in randomized clinical trials for peripheral artery disease: a systematic review
    Long, Chandler
    Williams, Abimbola O.
    Mcgovern, Alysha M.
    Jacobsen, Caroline M.
    Hargens, Liesl M.
    Duval, Sue
    Jaff, Michael R.
    INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2024, 23 (01)
  • [45] Yoga for low back pain: a systematic review of randomized clinical trials
    Posadzki, Paul
    Ernst, Edzard
    CLINICAL RHEUMATOLOGY, 2011, 30 (09) : 1257 - 1262
  • [46] A systematic review of Chinese randomized clinical trials of SSRI treatment of depression
    Zhang, Ying
    Becker, Thomas
    Ma, Yongchun
    Koesters, Markus
    BMC PSYCHIATRY, 2014, 14
  • [47] Clinical significance of ‘cardiometabolic memory’: a systematic review of randomized controlled trials
    Hiroshi Itoh
    Isao Kurihara
    Kazutoshi Miyashita
    Masami Tanaka
    Hypertension Research, 2017, 40 : 526 - 534
  • [48] Use of ghrelin in cachexia syndrome: a systematic review of clinical trials
    Mansson, Jessica V.
    Alves, Fernanda D.
    Biolo, Andreia
    Souza, Gabriela C.
    NUTRITION REVIEWS, 2016, 74 (11) : 659 - 669
  • [49] Dropouts in randomized clinical trials of Korean medicine interventions: a systematic review and meta-analysis
    Jeon, Sae-rom
    Nam, Dongwoo
    Kim, Tae-Hun
    TRIALS, 2021, 22 (01)
  • [50] The use of theory in process evaluations conducted alongside randomized trials of implementation interventions: A systematic review
    McIntyre, Stephen A.
    Francis, Jill J.
    Gould, Natalie J.
    Lorencatto, Fabiana
    TRANSLATIONAL BEHAVIORAL MEDICINE, 2020, 10 (01) : 168 - 178